ML364是一种泛素蛋白特异性肽酶(USP2)抑制剂，可用于乳腺癌的研究，摘自专利WO2016134026A1，化合物Figure10G。
CAS：1991986-30-1
分子式：C24H18F3N3O3S2
分子量：517.54
纯度：98%
存储：Store at -20°C
Background:
ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2), and can be used for the research of breast cancer, extracted from patent WO 2016134026 A1, compound Figure 10G.
[1]. Methods and materials for assessing chemotherapy responsiveness and treating cancer. WO 2016134026 A1
m.cnreagent.com
